Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 280

Results For "IMI"

4532 News Found

Takeda showcases digital health solutions at G20 Meeting in India
News | April 20, 2023

Takeda showcases digital health solutions at G20 Meeting in India

Showcased digital innovations: MyPKFit, SYNAPSE and Athena at the G20 Health Working Group Meeting


Zydus receives final approval from USFDA for Roflumilast Tablets, 250 mcg
Drug Approval | April 20, 2023

Zydus receives final approval from USFDA for Roflumilast Tablets, 250 mcg

Roflumilast reduces inflammation in the lungs that leads to chronic obstructive pulmonary disease (COPD)


Marksans Pharma completes acquisition of manufacturing site from Tevapharm India
News | April 20, 2023

Marksans Pharma completes acquisition of manufacturing site from Tevapharm India

Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards


Krsnaa Diagnostics bags tender from Municipal Corporation, Thane
Healthcare | April 20, 2023

Krsnaa Diagnostics bags tender from Municipal Corporation, Thane

The company will set up a MRI, CT Scan, Sonography- Ultrasound, X-Ray Center and Pathology Lab


Multiple sclerosis market to generate sales of $29.8 billion by 2030, forecasts GlobalData
News | April 19, 2023

Multiple sclerosis market to generate sales of $29.8 billion by 2030, forecasts GlobalData

Several late-stage pipeline products have the potential to address some of these unmet needs


Ministry of Ayush ensures the benchmarking of AI in traditional medicine, says Ayush Secretary
Digitisation | April 19, 2023

Ministry of Ayush ensures the benchmarking of AI in traditional medicine, says Ayush Secretary

Ministry of Ayush is leading a topic group on traditional medicine as part of Focus Group on Artificial Intelligence for Health (FG-AI4H)


Zydus receives final approval from the USFDA for Estradiol Transdermal System
Drug Approval | April 19, 2023

Zydus receives final approval from the USFDA for Estradiol Transdermal System

Estradiol Transdermal System USP, 0.014 mg/day (weekly) had annual sales of USD 1.9 mn in the United States


Enterprise Informatics central to solving productivity, staff and patient experience challenges, says Philips
Digitisation | April 18, 2023

Enterprise Informatics central to solving productivity, staff and patient experience challenges, says Philips

Digitization has unleashed a flood of data that presents a huge opportunity but is also overwhelming clinicians, nurses, and administrators


Vaniam appoints Paula Franson to lead Clinical Strategy & Solutions
People | April 18, 2023

Vaniam appoints Paula Franson to lead Clinical Strategy & Solutions

Franson will help biopharma clients design a phased approach to inform and execute clinical development plans


Zydus receives final approval from the USFDA for Isoproterenol Hydrochloride Injection
Drug Approval | April 17, 2023

Zydus receives final approval from the USFDA for Isoproterenol Hydrochloride Injection

Isoproterenol hydrochloride injection is indicated to improve hemodynamic status in patients in distributive shock and shock due to reduced cardiac output